Launch Your Career
From the Archive
News created: 29 Oct 2010
Macquarie University’s Faculty of Business and Economics and GlaxoSmithKline (GSK), leading international healthcare provider, have partnered for an exclusive Industry Based Learning / Co-op program. GSK are manufacturer’s of Panadol, Macleans and Sensodyne to name a few.
Faculty of Business and Economics second year undergraduate students will have the unique opportunity to experience the real work environment and learn directly from leaders in the industry.
The exciting twelve month paid program will allow students to work in a fun, friendly and supportive environment where they will gain invaluable hands on work experience that will build on their university learning and complement their future job applications. Students will receive full academic credit (FOBE200) for their involvement in the program.
Why you should apply?
- Be involved in hands-on valuable work and not just photocopying!
- Opportunity to work on key projects to build on your core technical and business skills
- Be actively involved in career networking forums
- Access to various internal and external training opportunities
- Report directly to an experienced line manager
- A one day corporate induction to GSK
- Develop great skills crucial for your future success in the workplace.
- Customer Marketing
- Procurement & Finance
- Human resources
Eligibility Criteria for 2011
To be eligible for this fabulous opportunity students must meet all the following criteria:
- Completing 2nd year of their undergraduate degree in 2010 at Macquarie University
- Be available to start placement in January 2011
- Have a minimum Credit average
- Be a Citizen or Permanent Resident of Australia
- Be available to attend a half day Assessment Centre in December 2010
GlaxoSmithKline (GSK)'s vision is to help Australians do more, feel better and live longer.
GSK Consumer Healthcare manufacturers and markets some of Australia’s best known brands including Panadol, Macleans, Sensodyne and Nicobate. It’s an exciting, dynamic and fast paced place to work and learn.
GSK invests more than $35 million a year in Australian R&D, and contribute to export revenue through pharmaceutical and consumer healthcare exports. It supplies more than 25 per cent of the world's medicinal opiate needs. GSK’s vaccines help protect Australians from illness, and literally millions of Australians use our consumer healthcare products.